|
- 2018
槲皮素对ACC-M细胞裸鼠移植瘤抑瘤效果的体内实验研究
|
Abstract:
摘要 目的:观察槲皮素对ACC-M细胞裸鼠移植瘤的抑制作用,探讨其作用机制。方法:常规将ACC-M 细胞接种于裸鼠右侧背部皮下,待肿瘤长至直径约6mm时随机分为5组,即空白对照组、槲皮素低、中、高剂量组、紫杉醇组,每组6只。定期测量肿瘤体积,绘制肿瘤生长曲线。给药3周后处死裸鼠,剥取肿瘤,称瘤重,计算抑瘤率。苏木精-伊红(hematoxylin-eosin,HE)染色,免疫组织化学法检测血管内皮生长因子(vascular endothelial growth factor,VEGF)和增殖细胞核抗原(proliferating cell nuclear antigen,PCNA)的表达情况。结果:给药3周后,各组的抑瘤率分别为11.45%、37.67%、42.49%、43.46%。VEGF表达的平均吸光度值分别为(0.420±0.039)、(0.367±0.040)、(0.315±0.033)、(0.270±0.016)、(0.298±0.044),各组比较差异有统计学意义(P<0.05);PCNA阳性表达率分别为(68.45±3.05)%、(58.84±3.33)%、(49.83±1.81)%、(44.90±1.85)%、(41.23±1.04)%,各组比较差异有统计学意义(P<0.01)。结论:槲皮素可抑制 ACC-M 细胞在裸鼠体内增殖,其机制可能通过抑制 VEGF和PCNA的表达发挥作用
[1] | Dillon PM, Chakraborty S, Moskaluk CA, et al. Adenoid cystic carcinoma: A review of recent advances, molecular targets, and clinical trials [J]. Head Neck, 2016, 38(4)∶620-627 |
[2] | Nabavi SF, Russo GL, Daglia M, et al. Role of quercetin as an alternative for obesity treatment: you are what you eat [J]. Food Chem, 2015, 179∶305-310 |
[3] | Luo CL, Liu YQ, Wang P, et al. The effect of quercetin nanoparticle on cervical cancer progression by inducing apoptosis, autophagy and anti-proliferation via JAK2 suppression [J]. Biomed Pharmacother, 2016, 82∶595-605 |
[4] | Zhao X,Wang Q,Yang S,et al. Quercetin inhibits angiogenesis by targeting calcineurin in the xenograft model of human breast cancer [J]. Eur J Pharmacol,2016,781∶60-68 |
[5] | Zhao J, Liu J, Wei T, et al. Quercetin-loaded nanomicelles to circumvent human castration-resistant prostate cancer <i>in vitro</i> and <i>in vivo</i> [J]. Nanoscale, 2016, 8(9)∶5126-5138 |
[6] | Rivera RA, Castillo-Pichardo L, Gerena Y, et al. Anti-breast cancer potential of quercetin via the Akt/AMPK/Mammalian target of Rapamycin (mTOR) signaling cascade [J]. PLoS One, 2016, 11(6)∶e0157251 |
[7] | Tao SF, He HF, Chen Q. Quercetin inhibits proliferation and invasion acts by up-regulating miR-146a in human breast cancer cells [J]. Mol Cell Biochem, 2015, 402(1-2)∶93-100 |
[8] | Pratheeshkumar P, Budhraja A, Son YO, et al. Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR- 2 regulated AKT/mTOR/P70S6K signaling pathways [J]. PLoS One, 2012, 7(10)∶e47516 |
[9] | 米静,张明宾,万光勇.槲皮素对人腺样囊性癌ACC-M细胞增殖和凋亡的影响及机制研究[J].中国口腔颌面外科杂志,2017,15(2)∶121-126 |
[10] | Kazemi-Lomedasht F, Pooshang-Bagheri K, Habibi-Anbouhi M, et al. <i>In vivo</i> immunotherapy of lung cancer using cross-species reactive vascular endothelial growth factor nanobodies [J]. Iran J Basic Med Sci, 2017, 20(5)∶489-496 |
[11] | 李晓光,卢会青,刘敏,等.增殖细胞核抗原在涎腺腺样囊性癌中的表达及其临床意义[J].重庆医学,2011,40(29)∶2969-2971 |
[12] | Shojaei F. Anti-angiogenesis therapy in cancer: current challenges and future perspectives [J]. Cancer Lett, 2012, 320(2)∶130-137 |
[13] | 蒋丽娟,郑阳,泥艳红,等.Avastin联合抗原致敏的DC-CTL细胞体外抑制口腔鳞癌细胞生长的实验研究[J].口腔医学研究,2016,32(8)∶848-852 |
[14] | Faur AC, Lazar E, Cornianu M. Vascular endothelial growth factor (VEGF) expression and microvascular density in salivary gland tumours [J]. APMIS, 2014, 122(5)∶418-426 |